Background: Curcumin is an antioxidant molecule that has been shown to attenuate ischemia/reperfusion (I/R) injury in several organ systems. In the present study, we aimed to evaluate the possible effects of curcumin on contractile response to agonists and histopathological alterations in rat esophagus subjected to mesenteric I/R. Materials and methods: Adult male Wistar albino rats were randomly allocated to 4 groups, namely group I: sham-operated animals (n=10); group II: animals subdued to I/R injury only (n=10) and laparotomy; 45 minutes of superior mesenteric artery ligation were followed by 2 hours of reperfusion, group III: curcumin/sham (n=10); 20 days before I/R, curcumin (200 mg/kg/) was administered by gastric gavage, and group IV: curcumin-I/R (n=10). Mesenteric ischemia/reperfusion model was generated by clamping the superior mesenteric artery for 45 min followed by reperfusion for 2 h. Oral administration of curcumin by gavage at a dose of 200 mg/kg/day lasted 20 days just before inducing the mesenteric ischemia. At the end of reperfusion period, all animals were sacrifi ced and esophagus samples were collected to assess the contractile response to agonists and histopathological alterations. Results: Ischemia/reperfusion signifi cantly decreased the contractile responses to carbachol and KCl and this decrease was attenuated by curcumin. Pretreatment with curcumin caused a remarkable decrease in histopathological parameters such as edema, congestion and infl ammatory cells.
Mesenteric ischemia is frequently encountered in multiple disease states and surgical procedures including cardiovascular interventions, small bowel transplantation mesenteric thrombosis, shock syndromes, and severe burns (1, 2) . The ensuing reperfusion is unavoidable and may induce downstream tissue injury. Intestinal ischemia and reperfusion injury can accelerate interactions between endothelium and different cell types resulting in microvascular injury, cellular necrosis, and apoptosis (3) (4) (5) (6) . During mesenteric ischemia/reperfusion (I/R), reactive oxygen species (ROS) attack the cell membrane constituents and thus bring about lipid peroxidation, membrane disintegration, and increased microvascular permeability. The latter induces activation and adhesion of polymorphonuclear neutrophils (PMNs), release of proinfl ammatory substances, and increased formation of ROS. Activated neutrophils in this tissue enhance ROS and cytotoxic protein production, which leads to an induction of infl ammatory cascade (3, 4) resulting in cell death and organ failure. The intensity of this infl ammatory reaction in postischemic tissue can be so great that the injury response to reperfusion is manifested also in distant organs. These remote effects of I/R are most frequently observed in the lung and cardiovascular system, and can possibly result in the development of systemic infl ammatory response syndrome (SIRS) and multiple organ dysfunction syndrome (MODS) (7) . To counter these processes, various therapeutic strategies have been attempted to attenuate the mesenteric I/R injury including antileukocyte and anti infl ammatory therapies, as well as glutamine, glycine and antioxidant supplementation (5, 8) .
Curcumin (diferuloyl methane) is a polyphenolic diketone found in Curcuma longa Linn. (Family Zingiberaceae). The rhizomes of the plant are a rich source of phenolic compounds, particularly curcumin. It possesses extensive pharmacological and therapeutic properties, including anticarcinogenic effects, and exhibits a potent antioxidant property (9) (10) (11) (12) . Curcumin is known to be a potent inhibitor of nuclear factor-κB (NF-κB). It has been shown to attenuate I/R injury in several organ systems. Recently, it has been reported that curcumin administration ameliorated I/R injury in rat kidney, myocardium, and nervous tissue (13) . Curcumin treatment has been recently shown to attenuate reperfusion injury in a superior mesenteric artery I/R model in rats (14) .
Despite numerous studies on the effects of I//R on the mesenteric smooth muscle responses, its probable effect on esophageal smooth muscle responses has not been delineated. Therefore, the present study was designed to investigate the effects of I/R on rat esophageal responses and the role of curcumin supplementation.
Materials and methods

Chemicals
Carbachol was purchased from Sigma (Sigma Chemical Co., St. Louis, MO, USA) and dissolved in double distilled water. Compounds used for preparing the Tyrode's solution, were purchased from Merck (Merck KGaA, Darmstadt, Germany).
Animals
In this study, 40 male Wistar-Albino rats weighing between 280 and 300 gr were used. Animals were kept under standardized conditions; 20±2 °C, 50±5 % humidity, 12/12 light-dark cycles at Selçuk University Experimental Medicine Research and Application Center. The rats were fed a standard laboratory diet with water ad libitum. The local ethics committee of our institution approved this study. The animals were randomly divided into four groups; ten animals in each groups. Sham: animals exposed to laparotomy without clamping the superior mesenteric artery (SMA); I/R (ischemiareperfusion): animals exposed to laparotomy with occlusion of SMA for 45 min, followed by 120 min of reperfusion period; Curcumin/ Sham: 200 mg/kg of curcumin as described before (15) (16) (17) was given with oral gavage for 20 days to animals who were thereafter exposed to laparotomy without clamping the SMA; Curcumin/I/R: 200 mg/kg of curcumin was given with oral gavage for 20 days to animals who were thereafter exposed to laparotomy with occlusion of SMA for 45 min, followed by 120 min of reperfusion period.
Ischemia-reperfusion protocol
Animals were anesthetized by intraperitoneal injection of ketamin hydrochloride plus xylazin. The abdomen was opened with a midline incision. The intestinal I/R injury was established by occluding the SMA with atraumatic microvascular clip for 45 min followed by 120 min reperfusion. Ischemia was recognized by absence of pulse or pale color of intestine. Following ischemia, the microvascular clamp was removed and reperfusion was confi rmed by restoration of pulsation and color prior to closing the incision. Sham-operated animals were submitted to the abdominal incision without I/R.
Curcumin supplementation
Curcumin (Curcuma longa; Turmeric) was purchased from Sigma Aldrich (C1386). Curcumin dissolved in corn oil (Sigma C8257). Rats in Curcumin/Sham and Curcumin/IR groups were given 200 mg/kg of curcumin with oral gavage for 20 days.
Preparation of esophagus
The rats were harvested by decapitation and almost 1.5 cm of thoracic portion of esophagus was excised. Esophageal smooth muscle strips were prepared and mounted in 20 ml organ chambers for isometric tension measurement. The organ chambers contained Tyrode's solution composed of (mmol l -1 ): NaCl 136.0; KCl 2.7; CaCl 2 1.8; MgCl 2 1.05; NaH 2 PO 4 .H 2 O 0.42; NaHCO 3 11.9; glucose 5.5. The solution was gassed with 95 % O 2 and 5 % CO 2 during the study, and the temperature was maintained at 37 °C . The strips were connected to a force transducer (BIOPAC MP36, Santa Barbara, California, USA) connected through amplifi ers to a ITBS08 Integrated Tissue Bath System (Commat, Ankara, Turkey). The strips were allowed to equilibrate for 90 min under a resting tension of 0.5 g before the experiments began. During this period the bath fl uid was routinely changed every 15 min.
Esophageal contractility
At the end of the equilibration period, carbachol (10
M) was added in a cumulative manner to the organ baths.
In another part of the study the same procedure was applied with cumulative addition (5-100 mM) of KCl to the organ baths. Each experiment was performed with a tissue sample taken from one animal.
Histopathologic examination
Immediately after death, the tissues in a 10% formaldehyde solution were processed in a cassette autotechnic tissue-processing equipment (Leica ASP 300). When the processing was completed, the tissues were embedded in paraffi n blocks and sections (5 m in thickness) taken by microtome instrument onto lysine laminin. The preparations stained with hematoxylin and eosin were evaluated by Olympus BX51 microscope.
The histopathological evaluation of tissue damage included the intensity of infl ammatory cell infi ltration, edema, congestion, hemorrhage erosion, muscular degeneration, necrosis and fi brosis. Each parameter was scored between 0 and 3 (0: normal, 1: mild, 2: moderate and 3: severe).
Biochemical Analysis
Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels were analyzed in serum samples by using commercially available kits (BenderMed System, Vienna, Austria) according to manufacturer's instructions. Myeloperoxidase (MPO) activity was analyzed in intestinal tissue to determine ischemia by using a commercially available kit (Hycult Biotechnology, Uden, The Netherlands) according to manufacturer's instructions. The protein content of tissues was determined by the method of Lowry et al (18) .
Statistical analysis
Concentrations of contractile agents causing 50 % of the maximal response (EC 50 ) were calculated from each individual concentration-response curve. The maximum effect values were calculated as a percentage of maximum response of tissue to carbachol and potassium chloride. Maximal responses and EC 50 values for curves obtained from each groups were compared by using the unpaired or paired Student's t test, as appropriate. The difference was assumed to be signifi cant at p<0.05.
The histopathological results were expressed as median (minmax). All numerical data were fi rst analyzed using the nonparametric Kruskal-Wallis test (whether there was a difference between groups) and then the Mann-Whitney U-test was performed to analyze two groups consecutively.
sigmoid curves (Fig. 1) . The dose-response curve obtained from tissues of animals subjected to I/R without administrating anything shifted to the right. In other words, the contractile responses induced by carbachol were signifi cantly and dose-dependently inhibited by the induction of IR (p<0.05). E max value for carbachol in the I/R control group was signifi cantly lower than in the sham-operated control group (Tab. 1). The IR-induced reduction in contractility was signifi cantly ameliorated by pretreatment with curcumin. Treatment of sham animals with curcumin has provided the same contractile response curve with similar E max value as sham alone group does.
In response to cumulative concentrations of KCl ranging from 2 mM to 10 mM, esophagus strips contracted in a dose-dependent fashion in all groups, rendering sigmoid curves with EC 50 and E max values (Fig. 2) . The contractile response induced by KCl was signifi cantly and dose-dependently inhibited by the induction of I/R. Reduced contractility due to I/R was signifi cantly ameliorated by curcumin pretreatment. Pretreating sham animals with curcumin caused similar dose-response curve to sham-operated group in respect of EC 50 and E max values.
Histopathological fi ndings
Based on histopathological analysis of 6 sections for each group, the most extensive changes in morphology were evident in I/R control group (Fig. 3) . Edema, congestion, and infl ammatory cell infi ltration were clearly observed and noticed as grades 2 and 3. In sham-operated control group, no pathological change was detected as demonstrated in picture A; grading as 0. The analysis also showed that the pretreatment with curcumin restored remarkably the typical alterations in morphology as depicted in Table 2 . Sections obtained from curcumin-pretreated sham group were observed with normal morphological appearance, identical to those from sham-operated control group (Tab. 3).
Biochemical fi ndings
Serum IL-6 and TNF-α levels were not different among the groups. Intestinal MPO activity was lower in Curcumin/Sham group compared to that in IR group (p<0.05) (Tab. 4).
Fig. 1. Carbachol concentration-response curves of esophagus from sham control rats, I/R control rats, curcumin-treated rats and curcumin-treated I/R rats. Each point is the mean ± SEM of six experiments.
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Results
Esophagus contractility
The addition of carbachol at concentration from 10 -9 M to 3x10 -4 M into organ bath fl uid resulted in a dose-dependent contractile effect on the esophageal strips from all groups, providing 
Discussion
The present study demonstrated that mesenteric I/R resulted in a decreased esophageal contractility in response to both carbachol, receptor-mediated induction, and KCl, non-receptor-mediated induction. Decreased contractile response observed also in non-receptor-mediated induction supports the possibility that ischemia/reperfusion may not alter the ligand-receptor interaction but rather changes the regulation of postreceptor processes (i.e. excitation-contraction coupling) (19) . Our data are consistent with these fi ndings. This study also reveals that curcumin pretreatment prevents the esophageal dysfunction and demonstrates a protective effect against esophageal damage resulting from mesenteric ischemia-reperfusion. This is the fi rst report to show that curcumin prevented an esophagus dysfunction induced by I/R. In this study, esophageal injury was assessed by histological method.
Oxidative stress plays an important role in mesenteric I/R injury. I/R injury leads to release of ROS or reactive nitrogen species (RNS) such as superoxide anion, hydroxyl radical, hydrogen peroxide, and peroxynitrite (20) . During reperfusion, when the oxygen is re-supplied, tissue injury could be further exacerbated depending on the duration and intensity of ischemia. Meanwhile, it produces an excess of xanthene oxidase and oxygen free radicals, which would aggressively and indiscriminately damage the cellular macromolecules including DNA, proteins, and lipids (21) . As it has previously been demonstrated, the development of I/R injury is associated with different representative pathologic processes such as congestion, hemorrhage, neutrophil accumulation and lipid peroxidation (22) . In this study, edema, congestion and infl ammation were clearly observed in mesenteric I/R group.
Aiming to improve the survival after acute mesenteric ischemia, a number of experimental studies have been carried out in order to test several pharmacological agents that might attenuate reperfusion injury (23) . Curcumin is an active ingredient of turmeric, and is a polyphenolic compound that is known for its potent antioxidant capacity (24) . Several factors support the sense of studies on the effect of curcumin administration on ischemia-related disorders, namely including the fact that curcumin is a naturally occurring substance. It is non-toxic to humans, tolerated as oral doses of up to 8000 mg/day, and evidenced safe by FDA approval (25) . It was also noticed that curcumin is relatively inexpensive.
A protective effect of curcumin against hepatic I/R injury has been reported by a mechanism related to its ability for over expression of antioxidant enzymes (26) . These factors together with the promising results of curcumin protective effi cacy in hepatic and cardiac I/R injury prompted us to evaluate and discover the immune-mediated mechanism of its effi cacy in protection against renal I/R injury and subsequent distant organ injury. However, the protective mechanism of curcumin effect on organ ischemia/ reperfusion is not fully understood. Pre-treatment with curcumin was found to markedly attenuate the I/R-induced acute lung injury, probably through improving the oxidative stress (27) . Furthermore, it has been shown that curcumin exerts a protective effect in several models of oxidant damage (28-30) including isoproterenolinduced cardiac injury (31) and I/R injury in rabbits (13) . Moreover, seven days of oral curcumin supplementation (3.6 g/d) has been shown to decrease the number of oxidative DNA adducts in malignant colorectal tissue suggesting that curcumin taken orally may reach suffi cient concentrations in the gastrointestinal tract (32) . In our study, curcumin pretreatment reduced the histopathologic indices such as edema, congestion and infl ammatory cells caused by mesenteric I/R. Modulation of infl ammatory response following I/R injury is an important component of tissue defense, mostly because infl ammation is the major component of cell death. Similarly, Karatepe et al (14) reported that curcumin pretreatment reduced the histopathologic indices of intestinal mucosal injury caused by mesenteric I/R. The investigators also reported that addition of curcumin to nutritional supplements reduced I/R injury through a mechanism suppressing the oxidative stress.
In the present study, not only did we observe a decrease in edema, congestion and infl ammatory cells, we also recorded a concomitant improvement in contractile response in case of curcumin pretreatment. The fi ndings of the present study revealed that systemic administration of curcumin improved remarkably the non-receptor-mediated (e.g. KCl-induced) and receptor-mediated (e.g. carbachol-induced) signifi cant reduction in esophageal contractions caused by I/R while the latter improvement even approached the sham-control levels.
Consequently, the present study is the fi rst to show that curcumin treatment restores the reduction in esophageal smoothmuscle responses to carbachol and KCl in mesenteric I/R model. Our results suggest that curcumin treatment may ameliorate the structural and functional damage observed in experimental I/R, mainly due to reducing the edema, congestion and infl ammation. Nevertheless, further studies are required to understand better the exact mechanism responsible for the protective effect of curcumin. 
Tab. 3. Comparison of histological damage of rat esophagus median (min-max).
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